Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 189.68

-0.2%

11:05 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Machaon who wrote (23941)	8/6/1998 12:32:00 PM
From: Henry Niman	Read Replies (1) of 32384

Bob, LGND's website ( ligand.com ) has a few words on the larger indications and off label use: "Ligand has an extensive Phase II clinical program in larger patient populations, including breast cancer, lung and prostate cancer, psoriasis and actinic keratoses.These trials will determine future NDA tracks and are designed to provide physicians with valuable information about additional activity of the drugs. This strategy - involving initial commercialization of products for niche patient populations with few therapeutic alternatives - allows Ligand to mount smaller, more affordable clinical trials, submit NDAs and launch its first products with a small but highly specialized oncology sales force. Ligand believes a sales force of 22 oncology sales specialists will be sufficient to launch the first product, and 35 should be adequate for the first four or five oncology products in the U.S. Similar numbers are projected for Europe. This is consistent with the experience of other companies that market oncology products".

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next